Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669785 · ClinicalTrials.gov registry record · NA
NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study
A NA study, sponsored by Dentsply International.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT01669785 is a NA study that has completed, run by Dentsply International. The registered enrollment target is 139 participants.
The verdict
NCT01669785, a NA study, has completed, sponsored by Dentsply International.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.
Interventions
- DEVICE Group C
- DEVICE Group A
- DEVICE Group B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669785
The ClinicalTrials.gov registry entry for NCT01669785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dentsply International, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Group C is the first listed.
NCT01669785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01669785 about?
NCT01669785 is a clinical study titled "NUPRO Sensodyne Prophylaxis Paste With NovaMin Sensitivity Relief Study". The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.
What is the current status of trial NCT01669785?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2012-03. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01669785?
The interventions under investigation include: Group C (DEVICE), Group A (DEVICE), Group B (DEVICE).
Who is sponsoring clinical trial NCT01669785?
This trial is sponsored by Dentsply International, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.